Lp-PLA2 levels are independant of statin treatment in dyslipidemic patients (original) (raw)
Related papers
Comparative evaluation of the effect of statin drugs in Hyperlipidaemic patients
2011
An overview of pleiotropic effect of statins in cardiovascular disease
Pharmacy & pharmacology international journal, 2018
Atherosclerosis, 2005
Statins: effects beyond cholesterol lowering
Nephrology Dialysis Transplantation, 2001
A correlation between LP-PLA2 and monocyte levels in atherosclerosis risk subjects
Infekciâ i Immunitet, 2022
Lp-PLA2: A new target for statin therapy
Current atherosclerosis reports, 2010
Statin use, hyperlipidaemia, and the risk of breast cancer
2002
Treatment of type III hyperlipoproteinemia with four different treatment regimens
Atherosclerosis, 1984
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
Journal of the American College of Cardiology, 2019
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins
2000
The American Journal of Cardiology, 2009
Dyslipidemia: End Stage Renal Disease and Hemodialysis
2009
Treating Hyperlipidemia for the Primary Prevention of Coronary Disease
Archives of internal medicine, 1998
Management of Dyslipidemia in the Metabolic Syndrome
American Journal of Cardiovascular Drugs, 2007
Atorvastatin treatment meets new European recommendations for the treatment of dyslipidemias
Cardiologia Croatica, 2012
Assessment of a laboratory method for the evaluation of hyperlipoproteinemia
1974
Cancer Causes & Control, 2010
Dyslipidemia in Metabolic Syndrome: an Overview of Lipoprotein- Related Disorders
International Journal of Cardiology and Lipidology Research, 2017
Characterization of metabolic syndrome in PLIC cohort
Atherosclerosis, 2017
Severity of coronary atherosclerosis related to lipoprotein concentration
BMJ, 1978
Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
Cancers, 2019
Secondary prevention of heart disease with statins: Authors' reply
BMJ, 2005
Saudi Pharmaceutical Journal, 2015
Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
Journal of the American College of Cardiology, 2014
Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle
BioEssays, 2007
Statin induced diabetes and its clinical implications
Journal of Pharmacology and Pharmacotherapeutics, 2014
Atherosclerosis, 2007
Psychologic Disorders and Statin Use: A Propensity Score-Matched Analysis
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
British Journal of Clinical Pharmacology, 2005
Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients
International Journal of Cardiology, 2013
The American Journal of Cardiology, 2000
Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease
Archives of Medical Research, 2014
Statins as potential therapeutic agents for healing disorders
… of Dermatology, 2010
ELEVATED LIPOPROTEIN (a) LEVELS SEEN IN PATIENTS WITH CORONARY ARTERY DISEASE
…, 2009
Dyslipidemia in women: etiology and management
International Journal of Women's Health, 2014